{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:43:28Z","timestamp":1787726608677,"version":"build-2784847793"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01763-y","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T08:10:59Z","timestamp":1766736659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An overview of gene and cell therapy approaches for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-7573","authenticated-orcid":false,"given":"Zahra","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-3692","authenticated-orcid":false,"given":"Alireza","family":"Zakaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-3880","authenticated-orcid":false,"given":"Asma","family":"Vafadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4043-9643","authenticated-orcid":false,"given":"Sajad","family":"Alavimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5315-5870","authenticated-orcid":false,"given":"Hossein","family":"Charami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4689-2095","authenticated-orcid":false,"given":"Zahra","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5320-7779","authenticated-orcid":false,"given":"Ali Honari","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-9874","authenticated-orcid":false,"given":"Abbas","family":"Rakhsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-9426","authenticated-orcid":false,"given":"Amir","family":"Savardashtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"37","key":"1763_CR1","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","volume":"33","author":"S Absalon","year":"2013","unstructured":"Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33(37):14645\u201314659","journal-title":"J Neurosci"},{"issue":"3","key":"1763_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030891","volume":"14","author":"LM Agavriloaei","year":"2025","unstructured":"Agavriloaei LM, Iliescu BF, Pintilie RM, Turliuc DM (2025) Therapeutic potential of experimental stereotactic hippocampal cell transplant in the management of Alzheimer\u2019s Disease. J Clin Med 14(3):891","journal-title":"J Clin Med"},{"issue":"7","key":"1763_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/stem.3016","volume":"37","author":"A Andrzejewska","year":"2019","unstructured":"Andrzejewska A, Lukomska B, Janowski M (2019) Concise review: mesenchymal stem cells: from roots to boost. Stem Cells 37(7):855\u2013864","journal-title":"Stem Cells"},{"key":"1763_CR4","doi-asserted-by":"crossref","unstructured":"Asmamaw M, Zawdie B (2021) Mechanism and applications of CRISPR\/Cas-9-mediated genome editing. Biol Targets Ther, 353\u2013361","DOI":"10.2147\/BTT.S326422"},{"key":"1763_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148368","author":"B Ataei","year":"2024","unstructured":"Ataei B, Hokmabadi M, Asadi S, Asadifard E, Zarch SMA, Najafi S, Bagheri-Mohammadi S (2024) A review of the advances, insights, and prospects of gene therapy for Alzheimer\u2019s disease: a novel target for therapeutic medicine. Gene. https:\/\/doi.org\/10.1016\/j.gene.2024.148368","journal-title":"Gene"},{"issue":"3","key":"1763_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10561-020-09896-3","volume":"22","author":"S Bagheri-Mohammadi","year":"2021","unstructured":"Bagheri-Mohammadi S (2021) Stem cell-based therapy as a promising approach in Alzheimer\u2019s disease: current perspectives on novel treatment. Cell Tissue Bank 22(3):339\u2013353. https:\/\/doi.org\/10.1007\/s10561-020-09896-3","journal-title":"Cell Tissue Bank"},{"issue":"4","key":"1763_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14712598.2022.2016695","volume":"22","author":"LL Bagno","year":"2022","unstructured":"Bagno LL, Salerno AG, Balkan W, Hare JM (2022) Mechanism of action of mesenchymal stem cells (MSCs): impact of delivery method. Expert Opin Biol Ther 22(4):449\u2013463","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"1763_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, Merezhko M, Uronen R-L, Huttunen HJ (2020) Mechanisms of secretion and spreading of pathological Tau protein. Cell Mol Life Sci 77(9):1721\u20131744","journal-title":"Cell Mol Life Sci"},{"key":"1763_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-021-10321-9","author":"HC Campos","year":"2022","unstructured":"Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SA, Longo BM (2022) Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer\u2019s disease. Stem Cell Rev Rep. https:\/\/doi.org\/10.1007\/s12015-021-10321-9","journal-title":"Stem Cell Rev Rep"},{"issue":"7\u20138","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/hum.2019.367","volume":"31","author":"MJ Castle","year":"2020","unstructured":"Castle MJ, Baltan\u00e1s FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH (2020) Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for Alzheimer\u2019s disease identifies a need for improved vector delivery. Hum Gene Ther 31(7\u20138):415\u2013422","journal-title":"Hum Gene Ther"},{"issue":"1","key":"1763_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-023-03410-8","volume":"14","author":"Y Choi","year":"2023","unstructured":"Choi Y, Shin S, Son HJ, Lee N-H, Myeong SH, Lee C, Na DL (2023) Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer\u2019s disease. Stem Cell Res Ther 14(1):178","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715\u2013736","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1763_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02193-1","volume":"40","author":"R Cuciniello","year":"2021","unstructured":"Cuciniello R, Filosa S, Crispi S (2021) Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics. J Exp Clin Cancer Res 40(1):383","journal-title":"J Exp Clin Cancer Res"},{"key":"1763_CR14","doi-asserted-by":"crossref","unstructured":"De Palma ST, Hermans EC, Shamorkina TM, Trayford C, van Rijt S, Heck AJ, de Theije CG (2025) Hypoxic Preconditioning Enhances the Potential of Mesenchymal Stem Cells to Treat Neonatal Hypoxic-Ischemic Brain Injury. Stroke","DOI":"10.1161\/STROKEAHA.124.048964"},{"issue":"3","key":"1763_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/biom13030549","volume":"13","author":"LM De Plano","year":"2023","unstructured":"De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A (2023) The role of the transcription factor Nrf2 in Alzheimer\u2019s disease: therapeutic opportunities. Biomolecules 13(3):549","journal-title":"Biomolecules"},{"issue":"9","key":"1763_CR16","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2909340","volume":"29","author":"H Deng","year":"2024","unstructured":"Deng H, Zhao J, Li J, Chen C, Hu Z, Wu X, Ge L (2024) Therapeutic efficacy of extracellular vesicles derived from stem cell for Alzheimer\u2019s disease: a meta-analysis study. Front Biosci Landmark 29(9):340","journal-title":"Front Biosci Landmark"},{"key":"1763_CR17","doi-asserted-by":"crossref","unstructured":"Ding X, Hu Y, Feng X, Wang Z, Song Q, Dai C, Fan C (2024) Enhanced Blood-Brain Barrier Penetrability of BACE1 SiRNA\u2010Loaded Prussian Blue Nanocomplexes for Alzheimer\u2019s Disease Synergy Therapy. Paper presented at the Exploration","DOI":"10.22541\/au.171023610.07919917\/v1"},{"issue":"3","key":"1763_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11055-024-01582-1","volume":"54","author":"E Eslami","year":"2024","unstructured":"Eslami E, Ghiyamihoor F, Sadr M, Ajdary M, Hakimpour S, Mehdizadeh R, Mehdizadeh M (2024) Intranasal delivery of human Wharton\u2019s jelly-derived mesenchymal stem cells alleviates A\u03b2-induced Alzheimer\u2019s symptoms in rat models by regulating neurotrophic and apoptotic factors. Neurosci Behav Physiol 54(3):374\u2013387","journal-title":"Neurosci Behav Physiol"},{"key":"1763_CR19","doi-asserted-by":"publisher","first-page":"1474012","DOI":"10.3389\/fphar.2025.1474012","volume":"16","author":"A \u00c9vora","year":"2025","unstructured":"\u00c9vora A, Garcia G, Rubi A, De Vitis E, Matos AT, Vaz AR, Brites D (2025) Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron\u2013glia crosstalk in Alzheimer\u2019s disease. Front Pharmacol 16:1474012","journal-title":"Front Pharmacol"},{"issue":"1","key":"1763_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener 11(1):4","journal-title":"Transl Neurodegener"},{"key":"1763_CR21","doi-asserted-by":"publisher","DOI":"10.34172\/bi.30795","volume":"15","author":"M Ghobadi","year":"2025","unstructured":"Ghobadi M, Heidari MF, Farhadi A, Shakerimoghaddam A, Ghorbani M, Hami Z, Ehtesham Naeim, Behroozi J (2025) The promise of gene therapy in common types of dementia. Bioimpacts 15:30795","journal-title":"Bioimpacts"},{"issue":"6","key":"1763_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s11596-020-2282-1","volume":"40","author":"J-l Gu","year":"2020","unstructured":"Gu J-l, Liu F (2020) Tau in alzheimer\u2019s disease: pathological alterations and an attractive therapeutic target. Curr Med Sci 40(6):1009\u20131021","journal-title":"Curr Med Sci"},{"issue":"1","key":"1763_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/acsami.1c15305","volume":"14","author":"S Gupta","year":"2021","unstructured":"Gupta S, Singh V, Ganesh S, Singhal NK, Sandhir R (2021) SiRNA mediated GSK3\u03b2 knockdown targets insulin signaling pathway and rescues alzheimer\u2019s disease pathology: evidence from in vitro and in vivo studies. ACS Appl Mater Interfaces 14(1):69\u201393","journal-title":"ACS Appl Mater Interfaces"},{"key":"1763_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05003-3","author":"A Gupta","year":"2025","unstructured":"Gupta A, Ghosh A, Sharma N, Gorain B (2025) Advancements in stem cell research for effective therapies against Alzheimer\u2019s disease: current investigation and future insight. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05003-3","journal-title":"Mol Neurobiol"},{"key":"1763_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.omtn.2021.02.032","volume":"24","author":"A Guyon","year":"2021","unstructured":"Guyon A, Rousseau J, B\u00e9gin F-G, Bertin T, Lamothe G, Tremblay JP (2021) Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro. Mol Ther Nucleic Acids 24:253\u2013263","journal-title":"Mol Ther Nucleic Acids"},{"key":"1763_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/alz.074768","volume":"19","author":"JD Haines","year":"2023","unstructured":"Haines JD, Farley J, Gannon S, Schlegel M, Castoreno A, Bisbe A, Avbersek A (2023) RNAi knockdown of microtubule-associated protein Tau prevents axonal damage and clears pre\u2010existing Tau aggregates in P301S transgenic tauopathy model mice. Alzheimer\u2019s & Dementia 19:e074768","journal-title":"Alzheimer's & Dementia"},{"issue":"759","key":"1763_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi4830","volume":"16","author":"J Han","year":"2024","unstructured":"Han J, Sul JH, Lee J, Kim E, Kim HK, Chae M, Lim Jeein, Kim Jongho, Kim Chanhee, Kim Jun-Sik, Cho Yoonsuk, Park Jae Hyung, Cho Yong Woo, Jo DG (2024) Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer\u2019s disease. Sci Transl Med 16(759):eadi4830. https:\/\/doi.org\/10.1126\/scitranslmed.adi4830","journal-title":"Sci Transl Med"},{"issue":"9","key":"1763_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/pharmaceutics12090801","volume":"12","author":"AS Hanafy","year":"2020","unstructured":"Hanafy AS, Schoch S, Lamprecht A (2020) CRISPR\/Cas9 delivery potentials in alzheimer\u2019s disease management: a mini review. Pharmaceutics 12(9):801","journal-title":"Pharmaceutics"},{"key":"1763_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2025.1612868","volume":"7","author":"C He","year":"2025","unstructured":"He C, Chen B, Yan C, Zhou X (2025) Stem cell and CRISPR\/Cas9 gene editing technology in Alzheimer\u2019s disease therapy: from basic research to clinical innovation. Front Genome Ed 7:1612868","journal-title":"Front Genome Ed"},{"issue":"8","key":"1763_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70021","volume":"42","author":"Z Heidari","year":"2024","unstructured":"Heidari Z, Fallahi J, Sisakht M, Safari F, Hosseini K, Bahmanimehr A, Razban V (2024) Impact of tissue factor gene knockout on coagulation properties of umbilical cord-derived multipotent mesenchymal stromal\/stem cells. Cell Biochem Funct 42(8):e70021","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"1763_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0196-9781(95)00021-B","volume":"16","author":"S Howell","year":"1995","unstructured":"Howell S, Nalbantoglu J, Crine P (1995) Neutral endopeptidase can hydrolyze \u03b2-amyloid (1\u201340) but shows no effect on \u03b2-amyloid precursor protein metabolism. Peptides 16(4):647\u2013652","journal-title":"Peptides"},{"issue":"2","key":"1763_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/kjm2.12797","volume":"40","author":"GJ Hu","year":"2024","unstructured":"Hu GJ, Jiang XY, Du SY, Zhang K, Chen Z (2024) miR-107-5p ameliorates neurological damage, oxidative stress, and immune responses in mice with alzheimer\u2019s disease by suppressing the Toll-like receptor 4 (TLR4)\/nuclear factor-kappaB(NF-\u03baB) pathway. Kaohsiung J Med Sci 40(2):119\u2013130. https:\/\/doi.org\/10.1002\/kjm2.12797","journal-title":"Kaohsiung J Med Sci"},{"issue":"14","key":"1763_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311420","volume":"36","author":"M Huang","year":"2024","unstructured":"Huang M, Zheng M, Song Q, Ma X, Zhang Q, Chen H, Jiang Gan, Zhou Songlei, Dai Chengxiang, Li Suke, Li Ping, Wang Hao, Zhang Ao, Huang Yukun, Chen Jun, Gao Xiaoling, Wang G (2024) Comparative proteomics inspired self-stimulated release hydrogel reinforces the therapeutic effects of MSC\u2010EVs on Alzheimer\u2019s disease. Adv Mater 36(14):2311420","journal-title":"Adv Mater"},{"key":"1763_CR34","doi-asserted-by":"publisher","first-page":"649646","DOI":"10.3389\/fnagi.2021.649646","volume":"13","author":"C Humpel","year":"2021","unstructured":"Humpel C (2021) Intranasal delivery of collagen-loaded Neprilysin clears beta-amyloid plaques in a transgenic alzheimer mouse model. Front Aging Neurosci 13:649646","journal-title":"Front Aging Neurosci"},{"key":"1763_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain MA, Laurent B, Plourde M (2021) APOE and Alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics. Front Neurosci 15:630502","journal-title":"Front Neurosci"},{"issue":"5","key":"1763_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","volume":"32","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Keiser MS, Meltzer JC, Fykstra DP, Dierksmeier SE, Hajizadeh S, Nakajima T (2024) APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of alzheimer disease. Mol Ther 32(5):1373\u20131386","journal-title":"Mol Ther"},{"key":"1763_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106413","author":"S Jain","year":"2024","unstructured":"Jain S, Bhushan B, Mishra A, Singh R (2024) Unlocking therapeutic potential of siRNA-based drug delivery system for treatment of Alzheimer\u2019s Disease. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2024.106413","journal-title":"J Drug Deliv Sci Technol"},{"key":"1763_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100269","author":"D Jakabek","year":"2025","unstructured":"Jakabek D, Isaacs A, De Strooper B, Tuszynski M, Lane R, Uspenskaya O, Mummery C (2025) CTAD taskforce: genetic therapies in Alzheimer\u2019s disease. The Journal of Prevention of Alzheimer\u2019s Disease. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100269","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"key":"1763_CR39","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c13150","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, Wang Z (2024a) Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of alzheimer\u2019s disease. ACS Nano. https:\/\/doi.org\/10.1021\/acsnano.3c13150","journal-title":"ACS Nano"},{"issue":"18","key":"1763_CR40","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, Wang Z (2024b) Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of alzheimer\u2019s disease. ACS Nano 18(18):11753\u201311768","journal-title":"ACS Nano"},{"issue":"5","key":"1763_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","volume":"18","author":"D Jovic","year":"2022","unstructured":"Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F, Luo Y (2022) A brief overview of global trends in MSC-based cell therapy. Stem Cell Rev Rep 18(5):1525\u20131545","journal-title":"Stem Cell Rev Rep"},{"issue":"12","key":"1763_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100151","volume":"47","author":"H Jung","year":"2024","unstructured":"Jung H, Jung Y, Seo J, Bae Y, Kim H-S, Jeong W (2024) Roles of extracellular vesicles from mesenchymal stem cells in regeneration. Molecules Cells 47(12):100151","journal-title":"Molecules Cells"},{"key":"1763_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102481","volume":"101","author":"PT Kamatham","year":"2024","unstructured":"Kamatham PT, Shukla R, Khatri DK, Vora LK (2024) Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: breaking the memory barrier. Ageing Res Rev 101:102481","journal-title":"Ageing Res Rev"},{"key":"1763_CR44","doi-asserted-by":"publisher","first-page":"1578138","DOI":"10.3389\/fncel.2025.1578138","volume":"19","author":"MS Khan","year":"2025","unstructured":"Khan MS, Qureshi N, Khan R, Son Y-O, Maqbool T (2025) CRISPR\/Cas9-based therapeutics as a promising strategy for management of alzheimer\u2019s disease: progress and prospects. Front Cell Neurosci 19:1578138","journal-title":"Front Cell Neurosci"},{"key":"1763_CR45","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0027","volume":"28","author":"S Kim","year":"2024","unstructured":"Kim S, Ullah I, Beloor J, Chung K, Kim J, Yi Y, Kang Eunhwa, Yun Gyeongju, Heo Seoyoun, Kim Seung Hyun, Kumar Priti, Lee Sang-Kyung, Pyun S-H (2024) Systemic treatment with siRNA targeting gamma-secretase activating protein inhibits amyloid-\u03b2 accumulation in Alzheimer\u2019s disease. Biomater Res 28:0027","journal-title":"Biomater Res"},{"key":"1763_CR46","doi-asserted-by":"crossref","unstructured":"Kim M, Kwon H, Sohn S, Lee WJ, Cho K, Kim GW (2025) Alzheimer\u2019s disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review). J Alzheimer\u2019s Disease, 13872877251391820","DOI":"10.1177\/13872877251391820"},{"key":"1763_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.omtn.2022.03.022","volume":"28","author":"E Konstantinidis","year":"2022","unstructured":"Konstantinidis E, Molisak A, Perrin F, Streubel-Gallasch L, Fayad S, Kim DY, Petri Karl, Aryee Martin J., Aguilar Ximena, Giedraitis Vilmantas, Joung J. Keith, Pattanayak Vikram, Essand Magnus, Erlandsson Anna, Berezovska Oksana, Ingelsson Martin, Gy\u00f6rgy B (2022) CRISPR-Cas9 treatment partially restores amyloid-\u03b2 42\/40 in human fibroblasts with the Alzheimer\u2019s disease PSEN1 M146L mutation. Mol Ther-Nucleic Acids 28:450\u2013461","journal-title":"Mol Ther-Nucleic Acids"},{"issue":"3","key":"1763_CR48","first-page":"203","volume":"5","author":"H Kumar","year":"2017","unstructured":"Kumar H, Mishra G, Sharma AK, Gothwal A, Kesharwani P, Gupta U (2017) Intranasal drug delivery: a non-invasive approach for the better delivery of neurotherapeutics. Pharm Nanatechnol 5(3):203\u2013214","journal-title":"Pharm Nanatechnol"},{"issue":"1","key":"1763_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2018.04.213","volume":"501","author":"R Kunimatsu","year":"2018","unstructured":"Kunimatsu R, Nakajima K, Awada T, Tsuka Y, Abe T, Ando K, Tanimoto K (2018) Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow\u2013derived mesenchymal stem cells. Biochem Biophys Res Commun 501(1):193\u2013198","journal-title":"Biochem Biophys Res Commun"},{"key":"1763_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.23","author":"JK Lam","year":"2015","unstructured":"Lam JK, Chow MY, Zhang Y, Leung SW (2015) siRNA versus miRNA as therapeutics for gene silencing. Mol Ther. https:\/\/doi.org\/10.1038\/mtna.2015.23","journal-title":"Mol Ther"},{"issue":"6","key":"1763_CR51","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/febs.13647","volume":"283","author":"KM Larmuth","year":"2016","unstructured":"Larmuth KM, Masuyer G, Douglas RG, Schwager SL, Acharya KR, Sturrock ED (2016) Kinetic and structural characterization of amyloid\u2010\u03b2 peptide hydrolysis by human angiotensin\u20101\u2010converting enzyme. FEBS J 283(6):1060\u20131076","journal-title":"FEBS J"},{"key":"1763_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112196","author":"S Lee","year":"2023","unstructured":"Lee S, Devanney NA, Golden LR, Smith CT, Schwartz JL, Walsh AE, Morillo-Segovia G (2023) APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2023.112196","journal-title":"Cell Rep"},{"issue":"2","key":"1763_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JAD-215145","volume":"84","author":"MJ Lennon","year":"2021","unstructured":"Lennon MJ, Rigney G, Raymont V, Sachdev P (2021) Genetic therapies for alzheimer\u2019s disease: a scoping review. J Alzheimer\u2019s Disease 84(2):491\u2013504","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"17","key":"1763_CR54","doi-asserted-by":"publisher","first-page":"e1681","DOI":"10.1212\/WNL.0000000000012727","volume":"97","author":"A Leuzy","year":"2021","unstructured":"Leuzy A, Janelidze S, Mattsson-Carlgren N, Palmqvist S, Jacobs D, Cicognola C, Hansson O (2021) Comparing the clinical utility and diagnostic performance of CSF P-Tau181, P-Tau217, and P-Tau231 assays. Neurology 97(17):e1681\u2013e1694","journal-title":"Neurology"},{"issue":"1","key":"1763_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-015-0066-5","volume":"6","author":"C-y Li","year":"2015","unstructured":"Li C-y, Wu X-y, Tong J-b, Yang X-x, Zhao J-l, Zheng Q-f, Ma Z-j (2015) Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 6(1):55. https:\/\/doi.org\/10.1186\/s13287-015-0066-5","journal-title":"Stem Cell Res Ther"},{"key":"1763_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.omtm.2019.12.012","volume":"17","author":"Y Li","year":"2020","unstructured":"Li Y, Wang Y, Wang J, Chong KY, Xu J, Liu Z, Shan C (2020) Expression of neprilysin in skeletal muscle by ultrasound-mediated gene transfer (sonoporation) reduces amyloid burden for AD. Mol Ther Methods Clin Dev 17:300\u2013308","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"1763_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G (2020b) APOE2: protective mechanism and therapeutic implications for alzheimer\u2019s disease. Mol Neurodegener 15(1):63","journal-title":"Mol Neurodegener"},{"issue":"17","key":"1763_CR58","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1021\/acschemneuro.1c00444","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Liu Q, Xue X, Lu X, Song J, He C, Zhao Y (2021) miR-29a\/b1 regulates BACE1 in aluminum-induced A\u03b2 deposition in vitro. ACS Chem Neurosci 12(17):3250\u20133265","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"1763_CR59","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.7150\/thno.53418","volume":"11","author":"C Liang","year":"2021","unstructured":"Liang C, Zou T, Zhang M, Fan W, Zhang T, Jiang Y, Sun Y (2021) MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of alzheimer\u2019s disease. Theranostics 11(9):4103","journal-title":"Theranostics"},{"key":"1763_CR60","doi-asserted-by":"publisher","first-page":"1209115","DOI":"10.3389\/fnagi.2023.1209115","volume":"15","author":"T Liang","year":"2023","unstructured":"Liang T, Wu Z, Li J, Wu S, Shi W, Wang L (2023) The emerging double-edged sword role of exosomes in Alzheimer\u2019s disease. Front Aging Neurosci 15:1209115","journal-title":"Front Aging Neurosci"},{"key":"1763_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149341","volume":"1849","author":"L Lin","year":"2025","unstructured":"Lin L, Li J, Yu Z, He J, Li Y, Jiang J, Xia Y (2025) Nrf2 activator tertiary butylhydroquinone enhances neural stem cell differentiation and implantation in Alzheimer\u2019s disease by boosting mitochondrial function. Brain Res 1849:149341","journal-title":"Brain Res"},{"issue":"6","key":"1763_CR62","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/jnc.15762","volume":"164","author":"DA Loeffler","year":"2023","unstructured":"Loeffler DA (2023) Experimental approaches for altering the expression of Abeta-degrading enzymes. J Neurochem 164(6):725\u2013763","journal-title":"J Neurochem"},{"issue":"5","key":"1763_CR63","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.4103\/NRR.NRR-D-23-01566","volume":"20","author":"Y Long","year":"2025","unstructured":"Long Y, Liu J, Wang Y, Guo H, Cui G (2025) The complex effects of miR-146a in the pathogenesis of Alzheimer\u2019s disease. Neural Regen Res 20(5):1309\u20131323","journal-title":"Neural Regen Res"},{"issue":"1","key":"1763_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-025-04131-w","volume":"16","author":"Y Lu","year":"2025","unstructured":"Lu Y, Xu Y, Zhou L, Wang S, Han Y, Wang K, Qin C (2025) Bone marrow mesenchymal stem cells derived cytokines associated with AKT\/IAPs signaling ameliorate Alzheimer\u2019s disease development. Stem Cell Res Ther 16(1):14","journal-title":"Stem Cell Res Ther"},{"key":"1763_CR65","doi-asserted-by":"publisher","first-page":"1576020","DOI":"10.3389\/fnagi.2025.1576020","volume":"17","author":"Y-n Ma","year":"2025","unstructured":"Ma Y-n, Hu X, Karako K, Song P, Tang W, Xia Y (2025) The potential and challenges of TREM2-targeted therapy in Alzheimer\u2019s disease: insights from the INVOKE-2 study. Front Aging Neurosci 17:1576020","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"1763_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043390","volume":"24","author":"E Marcello","year":"2023","unstructured":"Marcello E, Chiono V (2023) Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting. Int J Mol Sci 24(4):3390","journal-title":"Int J Mol Sci"},{"key":"1763_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnins.2019.00038","volume":"13","author":"S Mitra","year":"2019","unstructured":"Mitra S, Behbahani H, Eriksdotter M (2019) Innovative therapy for Alzheimer\u2019s disease-with focus on biodelivery of NGF. Front Neurosci 13:38","journal-title":"Front Neurosci"},{"issue":"14","key":"1763_CR68","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","volume":"101","author":"C Monteiro","year":"2023","unstructured":"Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Schauer SP (2023) Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate alzheimer disease: Lauriet. Neurology 101(14):e1391\u2013e1401","journal-title":"Neurology"},{"issue":"3","key":"1763_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103487","volume":"28","author":"KB Moore","year":"2023","unstructured":"Moore KB, Hung T-J, Fortin JS (2023) Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related tauopathies. Drug Discov Today 28(3):103487","journal-title":"Drug Discov Today"},{"issue":"1","key":"1763_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/ADR-210061","volume":"6","author":"NCdS Moreira","year":"2022","unstructured":"Moreira NCdS, Lima JEBdF, Marchiori MF, Carvalho I, Sakamoto-Hojo ET (2022) Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer\u2019s disease and future perspectives. J Alzheimers Dis Rep 6(1):177\u2013193","journal-title":"J Alzheimers Dis Rep"},{"key":"1763_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/alz.051871","volume":"17","author":"CJ Mummery","year":"2021","unstructured":"Mummery CJ, Junge C, Kordasiewicz HB, Mignon L, Moore KM, Yun C, Crean R (2021) Results of the first-in\u2010human, randomized, double\u2010blind, placebo\u2010controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer\u2019s disease. Alzheimers Dement 17:e051871","journal-title":"Alzheimers Dement"},{"key":"1763_CR72","first-page":"567","volume":"22","author":"JN Nojadeh","year":"2023","unstructured":"Nojadeh JN, Eryilmaz NSB, Erg\u00fcder B\u0130 (2023) CRISPR\/Cas9 genome editing for neurodegenerative diseases. EXCLI J 22:567","journal-title":"EXCLI J"},{"issue":"10","key":"1763_CR73","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.drudis.2022.07.003","volume":"27","author":"G Nordvall","year":"2022","unstructured":"Nordvall G, Forsell P, Sandin J (2022) Neurotrophin-targeted therapeutics: a gateway to cognition and more? Drug Discov Today 27(10):103318","journal-title":"Drug Discov Today"},{"issue":"1","key":"1763_CR74","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s13287-022-03129-y","volume":"13","author":"M Norte-Mu\u00f1oz","year":"2022","unstructured":"Norte-Mu\u00f1oz M, Gallego-Ortega A, Lucas-Ruiz F, Gonz\u00e1lez-Riquelme MJ, Changa-Espinoza YI, Galindo-Romero C, Agudo-Barriuso M (2022) Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas. Stem Cell Res Ther 13(1):430","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"1763_CR75","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3233\/JAD-200863","volume":"84","author":"M Pacheco-Herrero","year":"2021","unstructured":"Pacheco-Herrero M, Soto-Rojas LO, Reyes-Sabater H, Garc\u00e9s-Ramirez L, de la Cruz L\u00f3pez F, Villanueva-Fierro I, Luna-Mu\u00f1oz J (2021) Current status and challenges of stem cell treatment for Alzheimer\u2019s disease. J Alzheimers Dis 84(3):917\u2013935","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1763_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04804-w","volume":"80","author":"D Paes","year":"2023","unstructured":"Paes D, Schepers M, Willems E, Rombaut B, Tiane A, Solomina Y, Tibbo Amy, Blair Connor, Kyurkchieva Elka, Ricciarelli Roberta, Brullo Chiara, Fedele Ernesto, Bruno Olga, van den Hove Daniel, Vanmierlo Tim, Prickaerts Jos, Baillie GS (2023) Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-\u03b2 pathology. Cell Mol Life Sci 80(7):178","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"1763_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04804-w","volume":"80","author":"D Paes","year":"2023","unstructured":"Paes D, Schepers M, Willems E, Rombaut B, Tiane A, Solomina Y, Tibbo Amy, Blair Connor, Kyurkchieva Elka, Baillie George S., Ricciarelli Roberta, Brullo Chiara, Fedele Ernesto, Bruno Olga, van den Hove Daniel, Vanmierlo Tim, Prickaerts J (2023) Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-\u03b2 pathology. Cell Mol Life Sci 80(7):178. https:\/\/doi.org\/10.1007\/s00018-023-04804-w","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1763_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12787","volume":"72","author":"H Park","year":"2022","unstructured":"Park H, Kim J (2022) Activation of melatonin receptor 1 by CRISPR-Cas9 activator ameliorates cognitive deficits in an Alzheimer\u2019s disease mouse model. J Pineal Res 72(3):e12787. https:\/\/doi.org\/10.1111\/jpi.12787","journal-title":"J Pineal Res"},{"issue":"19","key":"1763_CR79","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.7150\/thno.103596","volume":"14","author":"D Peng","year":"2024","unstructured":"Peng D, Liu T, Lu H, Zhang L, Chen H, Huang Y, Zhang Q (2024) Intranasal delivery of engineered extracellular vesicles loaded with miR-206-3p Antagomir ameliorates Alzheimer\u2019s disease phenotypes. Theranostics 14(19):7623\u20137644. https:\/\/doi.org\/10.7150\/thno.103596","journal-title":"Theranostics"},{"issue":"2","key":"1763_CR80","first-page":"108","volume":"12","author":"SP Pezeshki","year":"2023","unstructured":"Pezeshki SP, Darabi MK, Nazeri Z, Sarkaki A, Rashidi M, Babaahmadi-Rezaei H, Cheraghzadeh M (2023) Mesenchymal stem cells therapy led to the improvement of spatial memory in rats with Alzheimer\u2019s disease through changing the expression of LncRNA TUSC7\/miR-449a\/PPAR\u03b3 and CD36 genes in the brain tissue. Int J Mol Cell Med 12(2):108","journal-title":"Int J Mol Cell Med"},{"key":"1763_CR81","doi-asserted-by":"crossref","unstructured":"Rafii MS, Aisen PS (2025) Amyloid-lowering immunotherapies for alzheimer disease: current status and future directions. Nat Reviews Neurol, 1\u20139","DOI":"10.1038\/s41582-025-01123-5"},{"key":"1763_CR82","doi-asserted-by":"crossref","unstructured":"Rash BG, Ramdas KN, Agafonova N, Naioti E, McClain-Moss L, Zainul Z, Leal T (2025) Allogeneic mesenchymal stem cell therapy with laromestrocel in mild alzheimer\u2019s disease: a randomized controlled phase 2a trial. Nat Med, 1\u201310","DOI":"10.1038\/s41591-025-03559-0"},{"issue":"1","key":"1763_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin A-C, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu C-C (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72","journal-title":"Mol Neurodegener"},{"key":"1763_CR84","doi-asserted-by":"publisher","first-page":"1011225","DOI":"10.3389\/fnmol.2022.1011225","volume":"15","author":"S Regmi","year":"2022","unstructured":"Regmi S, Liu DD, Shen M, Kevadiya BD, Ganguly A, Primavera R, Thakor AS (2022) Mesenchymal stromal cells for the treatment of Alzheimer\u2019s disease: strategies and limitations. Front Mol Neurosci 15:1011225","journal-title":"Front Mol Neurosci"},{"key":"1763_CR85","doi-asserted-by":"crossref","unstructured":"Roberts WS, Price S, Wu M, Parmar MS (2024) Emerging gene therapies for alzheimer\u2019s and parkinson\u2019s diseases: an overview of clinical trials and promising candidates. Cureus, 16(8)","DOI":"10.7759\/cureus.67037"},{"key":"1763_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122759","volume":"636","author":"B S\u00e1nchez-Dengra","year":"2023","unstructured":"S\u00e1nchez-Dengra B, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Gonz\u00e1lez-\u00c1lvarez M (2023) Access to the CNS: strategies to overcome the BBB. Int J Pharm 636:122759","journal-title":"Int J Pharm"},{"issue":"11","key":"1763_CR87","doi-asserted-by":"publisher","first-page":"15285","DOI":"10.18632\/aging.203088","volume":"13","author":"S Sha","year":"2021","unstructured":"Sha S, Shen X, Cao Y, Qu L (2021) Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer\u2019s disease in rat models via the microRNA-29c-3p\/BACE1 axis and the Wnt\/\u03b2-catenin pathway. Aging 13(11):15285","journal-title":"Aging"},{"key":"1763_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1518868","author":"A Shaikh","year":"2025","unstructured":"Shaikh A, Ahmad F, Teoh SL, Kumar J, Yahaya MF (2025) Neurotrophic factor alpha 1 gene therapy in Alzheimer\u2019s disease: scope and advancements. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2025.1518868","journal-title":"Front Mol Neurosci"},{"key":"1763_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105761","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024a) Advances in Alzheimer\u2019s disease: a multifaceted review of potential therapies and diagnostic techniques for early detection. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2024.105761","journal-title":"Neurochem Int"},{"key":"1763_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102483","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024b) Deciphering the role of miRNAs in Alzheimer\u2019s disease: predictive targeting and pathway modulation \u2013 a systematic review. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2024.102483","journal-title":"Ageing Res Rev"},{"key":"1763_CR91","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S506793","author":"C Sun","year":"2025","unstructured":"Sun C, Sha S, Shan Y, Gao X, Li L, Xing C, Guo Z, Du H (2025) Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer\u2019s disease. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S506793","journal-title":"Int J Nanomedicine"},{"key":"1763_CR92","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","volume":"342","author":"EA Taha","year":"2022","unstructured":"Taha EA, Lee J, Hotta A (2022) Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges. J Control Release 342:345\u2013361","journal-title":"J Control Release"},{"issue":"s1","key":"1763_CR93","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.3233\/JAD-240545","volume":"101","author":"MH Tuszynski","year":"2024","unstructured":"Tuszynski MH (2024) Growth factor gene therapy for Alzheimer\u2019s disease. J Alzheimers Dis 101(s1):S433\u2013S441","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1763_CR94","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.26864","volume":"95","author":"JM Vance","year":"2024","unstructured":"Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Haines JL (2024) Report of the APOE4 National Institute on Aging\/Alzheimer disease sequencing project consortium working group: reducing APOE4 in carriers is a therapeutic goal for Alzheimer\u2019s disease. Ann Neurol 95(4):625\u2013634","journal-title":"Ann Neurol"},{"issue":"5","key":"1763_CR95","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA (2019) Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease. Ann Neurol 85(5):726\u2013739","journal-title":"Ann Neurol"},{"issue":"1","key":"1763_CR96","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-021-00496-7","volume":"16","author":"H Walgrave","year":"2021","unstructured":"Walgrave H, Zhou L, De Strooper B, Salta E (2021) The promise of microRNA-based therapies in Alzheimer\u2019s disease: challenges and perspectives. Mol Neurodegener 16(1):76","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1763_CR97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","volume":"12","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Yuan Z (2016) Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and warton\u2019s jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother 12(1):85\u201396. https:\/\/doi.org\/10.1080\/21645515.2015.1030549","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1763_CR98","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41420-021-00620-y","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H, Liu Y, Li J, Wang T, Hei Y, Li H, Liu W (2021) Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP\/PS1 mice. Cell Death Discov 7(1):230","journal-title":"Cell Death Discov"},{"issue":"6","key":"1763_CR99","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, Yang X, Han Z-p, Qu F-f, Shao L, Shi Y-f (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34(6):747\u2013754","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"1763_CR100","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/jcma.0000000000001252","volume":"88","author":"C-K Wu","year":"2025","unstructured":"Wu C-K, Fuh J-L (2025) A 2025 update on treatment strategies for the alzheimer\u2019s disease spectrum. J Chin Med Assoc 88(7):495\u2013502. https:\/\/doi.org\/10.1097\/jcma.0000000000001252","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"1763_CR101","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101143","volume":"36","author":"X Xie","year":"2023","unstructured":"Xie X, Song Q, Dai C, Cui S, Tang R, Li S, Chang Jing, Li Ping, Wang Jintao, Gao Chao, Chen Hongzhuan, Chen Shengdi, Ren Rujing, Gao Xiaoling, Wang Gang, Li J (2023) Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatr 36(5):e101143","journal-title":"Gen Psychiatr"},{"issue":"3","key":"1763_CR102","doi-asserted-by":"publisher","first-page":"894","DOI":"10.7150\/thno.102315","volume":"15","author":"W Xiong","year":"2025","unstructured":"Xiong W, She W, Liu Y, Zhou H, Wang X, Li F, Jing S (2025) Clinical-grade human dental pulp stem cells improve adult hippocampal neural regeneration and cognitive deficits in alzheimer\u2019s disease. Theranostics 15(3):894","journal-title":"Theranostics"},{"key":"1763_CR103","doi-asserted-by":"crossref","unstructured":"Yang H (2023) CRISPR-Cas9: A promising tool in developing alzheimer\u2019s disease treatment. Highlights in Science, Engineering and Technology","DOI":"10.54097\/3c0tq464"},{"issue":"4","key":"1763_CR104","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.7150\/thno.81860","volume":"13","author":"T Yin","year":"2023","unstructured":"Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Yin Y (2023) Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against alzheimer\u2019s disease. Theranostics 13(4):1264","journal-title":"Theranostics"},{"key":"1763_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37","author":"X-H Zhang","year":"2015","unstructured":"Zhang X-H, Tee LY, Wang X-G, Huang Q-S, Yang S-H (2015) Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol Ther. https:\/\/doi.org\/10.1038\/mtna.2015.37","journal-title":"Mol Ther"},{"key":"1763_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.707268","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang H, Cao Y, Ma L, Wei Y, Li H (2021) Possible mechanisms of tau spread and toxicity in Alzheimer\u2019s disease. Frontiers in cell and developmental biology 9:707268","journal-title":"Frontiers in cell and developmental biology"},{"issue":"7","key":"1763_CR107","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-022-01122-3","volume":"17","author":"D Zhang","year":"2022","unstructured":"Zhang D, Wang G, Yu X, Wei T, Farbiak L, Johnson LT, Zhu H (2022) Enhancing CRISPR\/Cas gene editing through modulating cellular mechanical properties for cancer therapy. Nat Nanotechnol 17(7):777\u2013787","journal-title":"Nat Nanotechnol"},{"issue":"25","key":"1763_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300195","volume":"10","author":"R Zheng","year":"2023","unstructured":"Zheng R, Zhang L, Parvin R, Su L, Chi J, Shi K, Ye Fangfu, Huang X (2023) Progress and perspective of CRISPR-Cas9 technology in translational medicine. Adv Sci 10(25):2300195","journal-title":"Adv Sci"},{"issue":"4","key":"1763_CR109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4236\/aad.2023.124005","volume":"12","author":"TM Zohoncon","year":"2023","unstructured":"Zohoncon TM, Sawadogo J, Ouattara AK, Zoure AA, Ouedraogo MN, Ouedraogo P, Ouermi D (2023) Presymptomatic diagnosis and gene therapy for alzheimer\u2019s disease: Genomic, therapeutic, and ethical aspects\u2014a systematic review. Adv Alzheimer\u2019s Disease 12(4):55\u201374","journal-title":"Adv Alzheimer\u2019s Disease"},{"issue":"14","key":"1763_CR110","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1111\/febs.16939","volume":"291","author":"J \u017bukowska","year":"2024","unstructured":"\u017bukowska J, Moss SJ, Subramanian V, Acharya KR (2024) Molecular basis of selective amyloid-\u03b2 degrading enzymes in alzheimer\u2019s disease. FEBS J 291(14):2999\u20133029","journal-title":"FEBS J"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01763-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T10:02:15Z","timestamp":1766743335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01763-y","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}